Literature DB >> 1756083

Survival, growth and quality of life in children after orthotopic liver transplantation: a 5 year experience.

S E Chin1, R W Shepherd, G J Cleghorn, M K Patrick, G Javorsky, E Frangoulis, T H Ong, G Balderson, Y Koido, H Matsunami.   

Abstract

The aims of this study were to investigate outcome and to evaluate areas of potential ongoing concern after orthotopic liver transplantation (OLT) in children. Actuarial survival in relation to age and degree of undernutrition at the time of OLT was evaluated in 53 children (age 0.58-14.2 years) undergoing OLT for endstage liver disease. Follow-up studies of growth and quality of life were undertaken in those with a minimum follow-up period of 12 months (n = 26). The overall 3 year actuarial survival was 70%. Survival rates did not differ between age groups (actuarial 2 year survival for ages less than 1, 1-5 and greater than 5 years were 70, 70 and 69% respectively) but did differ according to nutritional status at OLT (actuarial 2 year survival for children with Z scores for weight less than -1 was 57%, greater than -1 was 95%; P = 0.004). Significant catch-up weight gain was observed by 18 months post-transplant, while height improved less rapidly. Quality of life (assessed by Vineland Adaptive Behaviour Scales incorporating socialization, daily living skills, communication and motor skills) was good (mean composite score 91 +/- 19). All school-aged children except one were attending normal school. Two children had mild to moderate intellectual handicap related to post-operative intracerebral complications. Satisfactory long-term survival can be achieved after OLT in children regardless of age but the importance of pre-operative nutrition is emphasized. Survivors have an excellent chance of a good quality of life and of satisfactory catch-up weight gain and growth.

Entities:  

Mesh:

Year:  1991        PMID: 1756083     DOI: 10.1111/j.1440-1754.1991.tb00424.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  13 in total

Review 1.  Who needs a liver transplant? (new disease specific indications).

Authors:  A Baker; A Dhawan; N Heaton
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 2.  Perioperative nutritional therapy in liver transplantation.

Authors:  Ahmed Hammad; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2014-01-29       Impact factor: 2.549

3.  Successful liver transplantation in babies under 1 year.

Authors:  S V Beath; G D Brook; D A Kelly; A J Cash; P McMaster; A D Mayer; J A Buckels
Journal:  BMJ       Date:  1993-10-02

Review 4.  Immunosuppressive drugs in paediatric liver transplantation.

Authors:  I D van Mourik; D A Kelly
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 5.  Measuring quality of life in paediatric patients.

Authors:  M A Connolly; J A Johnson
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 6.  Liver transplantation in children.

Authors:  Mohamed Rela; Anil Dhawan
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

7.  Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program.

Authors:  Paul R Atkison; B Catherine Ross; Sandy Williams; John Howard; John Sommerauer; Douglas Quan; William Wall
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

8.  Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates.

Authors:  Sonja M Swenson; John P Roberts; Sue Rhee; Emily R Perito
Journal:  Am J Transplant       Date:  2019-09-03       Impact factor: 8.086

9.  The management and long-term results of Japanese pediatric liver transplant recipients.

Authors:  M Ishikawa; H Kitatani; T Akiyama; Y Shimizu; G A Balderson; R W Shepherd; S V Lynch; T H Ong; R W Strong
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 10.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.